Meredith B. Metzger
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 7
- Fungal and yeast genetics research 4
- Protein Degradation and Inhibitors 2
- Cell Biology top 5%
- Endoplasmic Reticulum Stress and Disease 7
- Genetics top 5%
- Virus-based gene therapy research 1
- Oncology top 10%
- Cancer-related Molecular Pathways 3
-
- Autophagy in Disease and Therapy 3
-
- Viral gastroenteritis research and epidemiology 1
- Co-authors
- Allan M. WeissmanVentzislava A. HristovaRachel E. KlevitJonathan N. PrunedaSusan MichaelisSnorri S. ThorgeirssonHoward JaffeYasuhiro Setoguchi
- Partner nations
- United StatesFrance
In The Last Decade
Meredith B. Metzger
13 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Molecular Biology 1.4k
- Cell Biology 320
- Genetics 383
- Oncology 335
- Aging 15
Countries citing papers authored by Meredith B. Metzger
This map shows the geographic impact of Meredith B. Metzger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith B. Metzger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith B. Metzger more than expected).
Fields of papers citing papers by Meredith B. Metzger
This network shows the impact of papers produced by Meredith B. Metzger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith B. Metzger. The network helps show where Meredith B. Metzger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meredith B. Metzger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 50 | |
| 2 | 2019 | 1 | |
| 3 | 2018 | 24 | |
| 4 | 2017 | 6 | |
| 5 | 2015 | 26 | |
| 6 | RING-type E3 ligases: Master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitinationbreakdown → | 2013 | 462 |
| 7 | 2013 | 64 | |
| 8 | HECT and RING finger families of E3 ubiquitin ligases at a glancebreakdown → | 2012 | 472 |
| 9 | 2008 | 50 | |
| 10 | 2008 | 113 | |
| 11 | 1992 | 386 | |
| 12 | Pharmacological properties of the new orally active angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl] -(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498). | 1984 | 26 |
| 13 | Lysozyme Activity of Rabbit Sera and Testicular Juice during the Development of Syphilitic Lesions. | 1963 | 0 |
| 14 | THE INFLUENCE OF ZYMOSAN, CORTISONE AND X-RAYS ON THE COURSE OF EXPERIMENTAL TOXOPLASMOSIS IN WHITE RATS. | 1963 | 9 |
About Meredith B. Metzger
Meredith B. Metzger is a scholar working on Cell Biology, Molecular Biology and Microbiology, having authored 14 papers that have together received 1.7k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (7 papers), Endoplasmic Reticulum Stress and Disease (7 papers), Fungal and yeast genetics research (4 papers), Autophagy in Disease and Therapy (3 papers), Cancer-related Molecular Pathways (3 papers), Protein Degradation and Inhibitors (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Molecular Biology (1.4k citations), Cell Biology (320 citations) and Genetics (383 citations). Meredith B. Metzger has collaborated with scholars based in United States and France. Frequent co-authors include Allan M. Weissman, Ventzislava A. Hristova, Rachel E. Klevit, Jonathan N. Pruneda, Susan Michaelis, Snorri S. Thorgeirsson, Howard Jaffe, Yasuhiro Setoguchi, Timothy W. Gant and Claire Danel.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.